Discovery of VU6028418: A Highly Selective and Orally Bioavailable M4 Muscarinic Acetylcholine Receptor Antagonist. - Spock M; Carter TR; Bollinger KA; Han C; Baker LA; Rodriguez AL; Peng L; Dickerson JW; Qi A; Rook JM; O'Neill JC; Watson KJ; et al. (ACS medicinal chemistry letters, 2021)